Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

967 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
S100A8/A9 Induced by Interaction with Macrophages in Esophageal Squamous Cell Carcinoma Promotes the Migration and Invasion of Cancer Cells via Akt and p38 MAPK Pathways.
Tanigawa K, Tsukamoto S, Koma YI, Kitamura Y, Urakami S, Shimizu M, Fujikawa M, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H. Tanigawa K, et al. Among authors: tsukamoto s. Am J Pathol. 2022 Mar;192(3):536-552. doi: 10.1016/j.ajpath.2021.12.002. Epub 2021 Dec 24. Am J Pathol. 2022. PMID: 34954212 Free article.
Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression.
Shimizu M, Koma YI, Sakamoto H, Tsukamoto S, Kitamura Y, Urakami S, Tanigawa K, Kodama T, Higashino N, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H. Shimizu M, et al. Among authors: tsukamoto s. Cancers (Basel). 2021 Sep 10;13(18):4552. doi: 10.3390/cancers13184552. Cancers (Basel). 2021. PMID: 34572779 Free PMC article.
A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer.
Okamoto T, Yano T, Shimokawa M, Takeo S, Yamazaki K, Sugio K, Takenoyama M, Nagashima A, Tsukamoto S, Hamatake M, Yokoyama H, Ueda H, Motohiro A, Tagawa T, Shoji F, Kometani T, Saito G, Fukuyama Y, Toyokawa G, Osoegawa A, Emi Y, Maehara Y; Kyushu University Lung Surgery Study Group (KLSS) Japan. Okamoto T, et al. Among authors: tsukamoto s. Lung Cancer. 2018 Oct;124:255-259. doi: 10.1016/j.lungcan.2018.08.015. Epub 2018 Aug 19. Lung Cancer. 2018. PMID: 30268470 Clinical Trial.
Invasive thymoma with long-term survival by extensive reoperation.
Sakada T, Sugio K, Nishioka K, Tsukamoto S, Ushijima C, Yamazaki K, Okamoto T, Kase S, Koga T, Sugimachi K. Sakada T, et al. Among authors: tsukamoto s. Respiration. 1999;66(2):167-9. doi: 10.1159/000029361. Respiration. 1999. PMID: 10202323
Chronological analysis of the gut microbiome for efficacy of atezolizumab-based immunotherapy in non-small cell lung cancer: Protocol for a multicenter prospective observational study.
Shoji F, Miura N, Tagawa T, Tsukamoto S, Okamoto T, Yamazaki K, Hamatake M, Takeo S. Shoji F, et al. Among authors: tsukamoto s. Thorac Cancer. 2022 Oct;13(19):2829-2833. doi: 10.1111/1759-7714.14640. Epub 2022 Sep 5. Thorac Cancer. 2022. PMID: 36063818 Free PMC article.
967 results